3140.0000 -37.20 (-1.17%)
NSE Aug 04, 2025 11:15 AM
Volume: 34,067
 

3140.00
-1.17%
Emkay
DLPL reported a steady Q4, with EBITDA beating street/our estimates by 6% and adj PAT improving 34% on YoY basis. Strong performance in core markets (Delhi NCR), buoyed by network expansion, offset the persistent muted performance of Suburban (mid-single digit revenue growth).
Number of FII/FPI investors decreased from 382 to 358 in Jun 2025 qtr
More from Dr. Lal Pathlabs Ltd.
All Rapid Results
Recommended